Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C3H7NO2 |
Molecular Weight | 89.0932 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](N)C(O)=O
InChI
InChIKey=QNAYBMKLOCPYGJ-UWTATZPHSA-N
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16154544
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16154544
D-alanine is an isomer of non-essential L-amino acid. D isomer is found in the cell walls of bacteria, but not in bacterial proteins. It was discovered, that being an endogenous agonist of the glycine site of the N-methyl-d-aspartate (NMDA) receptor, D-alanine can have beneficial effects on schizophrenia.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16154544 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Resistance to D-cycloserine in the tubercle bacilli: mutation rate and transport of alanine in parental cells and drug-resistant mutants. | 1971 May |
|
The genome of Mycobacterium leprae: a minimal mycobacterial gene set. | 2001 |
|
Sequencing of the ddl gene and modeling of the mutated D-alanine:D-alanine ligase in glycopeptide-dependent strains of Enterococcus faecium. | 2001 Apr |
|
Rapid identification of Enterococcus durans and Enterococcus hirae by PCR with primers targeted to the ddl genes. | 2001 Oct |
|
First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. | 2002 Sep |
|
Nosocomial infection with vancomycin-dependent enterococci. | 2004 Jul |
|
Phylogenomics of the reproductive parasite Wolbachia pipientis wMel: a streamlined genome overrun by mobile genetic elements. | 2004 Mar |
|
Crystallization and preliminary crystallographic analysis of D-alanine-D-alanine ligase from Streptococcus mutans. | 2007 Sep 1 |
|
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI). | 2008 Feb |
|
D-Alanine:D-alanine ligase as a new target for the flavonoids quercetin and apigenin. | 2008 Nov |
|
Comparative genomic analyses of nickel, cobalt and vitamin B12 utilization. | 2009 Feb 10 |
|
Mutation in a D-alanine-D-alanine ligase of Azospirillum brasilense Cd results in an overproduction of exopolysaccharides and a decreased tolerance to saline stress. | 2009 Jan |
|
Genome subtraction for novel target definition in Salmonella typhi. | 2009 Oct 11 |
|
Molecular characterization of glycopeptide-resistant enterococci from hospitals of the picardy region (france). | 2010 |
|
Selenocysteine, pyrrolysine, and the unique energy metabolism of methanogenic archaea. | 2010 Aug 17 |
|
Aza-1,2,3-triazole-3-alanine synthesis via copper-catalyzed 1,3-dipolar cycloaddition on aza-progargylglycine. | 2010 Aug 6 |
|
Proteomic characterization of vanA-containing Enterococcus recovered from Seagulls at the Berlengas Natural Reserve, W Portugal. | 2010 Sep 21 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16154544
100 mg/kg/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28286870
It was studied the effect of D-alanine (10 mM), D-leucine (10 mM), D-methionine (10 mM), D-tryptophan (10 mM), and D-tyrosine (10 uM and 1 mM) on biofilm formation in two commonly studied laboratory strains of P. aeruginosa: PAO1 and PA14. In strains PAO1 and PA14, the addition of D-amino acids did not result in an inhibitory effect on biofilm growth in 24-well plates. Repeating the study in 96-well plates confirmed the findings that D-amino acids do not inhibit biofilm formation of P. aeruginosa. It was concluded that D-amino acids only slow the production of biofilms rather than completely prevent biofilm formation.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID3045649
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
29949
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
E3UDS4613U
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
71080
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
15570
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
DB01786
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
206-418-1
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
m1467
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
57416
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
158286
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
338-69-2
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD